Also, the tone and body language of the conference call suggested to me that Teva was consigned to history in its links to MSB's CHF program.
By way of a nautical metaphor: the Good Ship Teva has steamed away over the horizon, her crew having jettisoned overboard the extra weight that was the trophy for the once-vaunted International Biotech of the Year Award, 2010.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.065(3.77%) |
Mkt cap ! $2.291B | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.81 | $1.70 | $7.807M | 4.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39187 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 12767 | 4 |
View Market Depth
| Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |